F04

BIOLOGICS IN PSORIASIS

15.00 – 16.30  ROOFGARDEN

J. C. Prinz (Munich, Germany)
W. Gulliver (St. John's, Canada)

Learning Objectives:

  1. assess particular indication for biologics in psoriasis
  2. consider the role of infections in adverse events
  3. judge on perspectives associated with treatment

Description:

The aim of the workshop is to address particular aspects that may arise during treatment of psoriasis with biologics in clinical practice. As such the presentations should provide information related to therapeutic decisions, prevention of potential adverse events, dealing with unforeseen incidents and consider long-term perspectives for psoriasis patients associated with treatments based on biological products.

F04.1

15:00

Treatment of Psoriasis: Particular Indications for the Different Biologics

H. Bachelet (Paris, France)

F04.2

15:22

Long Term Prognosis in Patients and How They are Affected by Biologics and Conventional Therapy

W. Gulliver (St. John's, Canada)

F04.3

15:45

Severe Adverse Events of Biologics: The Role of Infection in Lupus-like Syndrome, Demyelination and Polyneuropathies

Jörg C. Prinz (Munich, Germany)

F04.4

16:08

Biologics and Tuberculosis: Interpretation of Test Results, Prevention of Exacerbation

G. Girolomoni (Verona, Italy)

»BACK